Market Research Logo

Global Opioid-Induced Constipation Market Insights, Forecast to 2025

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,900 147 Pages QYResearch Group August, 2018 QYR15762897
Lowest Prices Guaranteed
Price from $3,900
Length 147 Pages
Publisher QYResearch Group
Published Date August, 2018
SKU QYR15762897
$3,900
$7,800
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093

Global Opioid-Induced Constipation Market Insights, Forecast to 2025

This report studies the Opioid-Induced Constipation market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Opioid-Induced Constipation market by product and Application/end industries.

In the last several years, global market of Opioid-Induced Constipation developed smoothly, with an average growth rate of 3.85% from the forecast period 2019 to 2025. In 2017, global revenue of Opioid-Induced Constipation is nearly 2112 M USD; the actual Sales is about 175.5 million units.

The major players in global market include
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi

Geographically, this report split global into several key Regions, with sales and revenue, market share and growth rate of Opioid-Induced Constipation for these regions, from 2016 to 2025 (forecast)
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
Korea
Southeast Asia
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of Central & South America
Middle East & Africa
Middle East
Africa

Based on product, the Opioid-Induced Constipation market is primarily split into
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others

On the basis on the end users/Application, this report covers
Hospital
Pharmacy
Other


1 Study Coverage
1.1 Opioid-Induced Constipation Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type
1.4.2 Methylnaltrexone Bromide
1.4.3 Lubiprostone
1.4.4 Naloxegol
1.4.5 Others
1.5 Market by Application
1.5.1 Global Opioid-Induced Constipation Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid-Induced Constipation Market Size
2.1.1 Global Opioid-Induced Constipation Revenue 2016-2025
2.1.2 Global Opioid-Induced Constipation Sales 2016-2025
2.2 Opioid-Induced Constipation Growth Rate by Regions
2.2.1 Global Opioid-Induced Constipation Sales by Regions
2.2.2 Global Opioid-Induced Constipation Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Opioid-Induced Constipation Sales by Manufacturers
3.1.1 Opioid-Induced Constipation Sales by Manufacturers
3.1.2 Opioid-Induced Constipation Sales Market Share by Manufacturers
3.2 Opioid-Induced Constipation Revenue by Manufacturers
3.2.1 Opioid-Induced Constipation Revenue by Manufacturers (2016-2018)
3.2.2 Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2018)
3.2.3 Global Opioid-Induced Constipation Market Concentration Ratio
3.3 Opioid-Induced Constipation Price by Manufacturers
3.4 Opioid-Induced Constipation Headquarters, Product Types
3.4.1 Opioid-Induced Constipation Manufacturers Headquarters
3.4.2 Manufacturers Opioid-Induced Constipation Product Category
3.4.3 Establish Date of Manufacturers
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Opioid-Induced Constipation Sales by Type
4.2 Global Opioid-Induced Constipation Revenue by Type
4.3 Opioid-Induced Constipation Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Opioid-Induced Constipation Breakdown Data by Application
6 North America
6.1 North America Opioid-Induced Constipation by Countries
6.1.1 North America Opioid-Induced Constipation Sales by Countries
6.1.2 North America Opioid-Induced Constipation Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioid-Induced Constipation by Type
6.3 North America Opioid-Induced Constipation by Application
6.4 North America Opioid-Induced Constipation by Company
7 Europe
7.1 Europe Opioid-Induced Constipation by Countries
7.1.1 Europe Opioid-Induced Constipation Sales by Countries
7.1.2 Europe Opioid-Induced Constipation Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid-Induced Constipation by Type
7.3 Europe Opioid-Induced Constipation by Application
7.4 Europe Opioid-Induced Constipation by Company
8 Asia Pacific
8.1 Asia Pacific Opioid-Induced Constipation by Countries
8.1.1 Asia Pacific Opioid-Induced Constipation Sales by Countries
8.1.2 Asia Pacific Opioid-Induced Constipation Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Southeast Asia
8.2 Asia Pacific Opioid-Induced Constipation by Type
8.3 Asia Pacific Opioid-Induced Constipation by Application
8.4 Asia Pacific Opioid-Induced Constipation by Company
9 Central & South America
9.1 Central & South America Opioid-Induced Constipation by Countries
9.1.1 Central & South America Opioid-Induced Constipation Sales by Countries
9.1.2 Central & South America Opioid-Induced Constipation Revenue by Countries
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Opioid-Induced Constipation by Type
9.3 Central & South America Opioid-Induced Constipation by Application
9.4 Central & South America Opioid-Induced Constipation by Company
10 Middle East and Africa
10.1 Middle East and Africa Opioid-Induced Constipation by Countries
10.1.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries
10.1.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries
10.1.3 Middle East
10.1.4 Africa
10.2 Middle East and Africa Opioid-Induced Constipation by Type
10.3 Middle East and Africa Opioid-Induced Constipation by Application
10.4 Middle East and Africa Opioid-Induced Constipation by Company
11 Analysis of Opioid-Induced Constipation Industry Key Manufacturers
11.1 Takeda Pharmaceuticals
11.1.1 Company Profile
11.1.2 Product Information
11.1.3 Sales, Price and Revenue
11.2 Bayer
11.2.1 Company Profile
11.2.2 Product Information
11.2.3 Sales, Price and Revenue
11.3 Sanofi
11.3.1 Company Profile
11.3.2 Product Information
11.3.3 Sales, Price and Revenue
11.4 Mallinckrodt
11.4.1 Company Profile
11.4.2 Product Information
11.4.3 Sales, Price and Revenue
11.5 Salix (Bausch Health)
11.5.1 Company Profile
11.5.2 Product Information
11.5.3 Sales, Price and Revenue
11.6 AstraZeneca
11.6.1 Company Profile
11.6.2 Product Information
11.6.3 Sales, Price and Revenue
11.7 Progenics Pharmaceuticals
11.7.1 Company Profile
11.7.2 Product Information
11.7.3 Sales, Price and Revenue
11.8 Purdue Pharm
11.8.1 Company Profile
11.8.2 Product Information
11.8.3 Sales, Price and Revenue
11.9 Nektar Therapeutics
11.9.1 Company Profile
11.9.2 Product Information
11.9.3 Sales, Price and Revenue
11.10 Daiichi Sankyo
11.10.1 Company Profile
11.10.2 Product Information
11.10.3 Sales, Price and Revenue
11.11 Prestige
11.11.1 Company Profile
11.11.2 Product Information
11.11.3 Sales, Price and Revenue
11.12 GSK
11.12.1 Company Profile
11.12.2 Product Information
11.12.3 Sales, Price and Revenue
11.13 Shionogi
11.13.1 Company Profile
11.13.2 Product Information
11.13.3 Sales, Price and Revenue
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Opioid-Induced Constipation Drugs R&D Cost Analysis
13.1.2 Opioid-Induced Constipation Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Opioid-Induced Constipation Product Picture
Table Opioid-Induced Constipation Key Market Segments
Table Key Manufacturers Opioid-Induced Constipation Covered in 2017
Table Global Opioid-Induced Constipation Comparison by Types
Table Global Opioid-Induced Constipation Market by Type (2017-2025) (K Unit) & (Million US$)
Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2017
Figure Methylnaltrexone Bromide Product Picture
Figure Lubiprostone Product Picture
Figure Naloxegol Product Picture
Figure Others Product Picture
Table Global Opioid-Induced Constipation Market by Application (2018-2025) (K Unit)
Figure Hospital
Figure Pharmacy
Figure Opioid-Induced Constipation Report Years Considered
Figure Global Opioid-Induced Constipation Market Size 2016-2025 (Million US$)
Figure Global Opioid-Induced Constipation Sales 2016-2025 (K Unit)
Table Global Opioid-Induced Constipation Market Size by Regions 2016-2025 (K Unit) & (Million US$)
Table Global Opioid-Induced Constipation Sales by Regions 2016-2025 (K Unit)
Table Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
Figure Global Opioid-Induced Constipation Sales Market Share by Regions 2016-2025
Figure 2017 Global Opioid-Induced Constipation Sales Market Share by Regions
Table Global Opioid-Induced Constipation Revenue by Regions 2016-2025 (Million US$)
Table Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions 2016-2025
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2017
Table Global Opioid-Induced Constipation Sales by Manufacturers (2016-2018) (K Unit)
Table Global Opioid-Induced Constipation Sales Share by Manufacturers (2016-2018)
Figure Global Opioid-Induced Constipation Sales Share by Manufacturers in 2017
Table Opioid-Induced Constipation Revenue by Manufacturers (2016-2018) (Million US$)
Table Opioid-Induced Constipation Revenue Share by Manufacturers (2016-2018)
Figure Opioid-Induced Constipation Revenue Share by Manufacturers in 2017
Figure 2017 Opioid-Induced Constipation Revenue Market Share by Manufacturers
Figure 2017 Opioid-Induced Constipation Revenue Market Share of Top 6 Manufacturers
Table Key Manufacturers Opioid-Induced Constipation Price (2016-2018) (USD/Unit)
Table Opioid-Induced Constipation Manufacturers Headquarters
Table Manufacturers Opioid-Induced Constipation Product Category
Table Establish Date Manufacturers
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
Table Global Opioid-Induced Constipation Sales Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2017
Table Global Opioid-Induced Constipation Revenue by Type (2016-2025) (Million US$)
Table Global Opioid-Induced Constipation Revenue Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2025)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2017
Table Opioid-Induced Constipation Price by Type 2016-2015(USD/Unit)
Figure Global Sales Opioid-Induced Constipation Market Share by Application in 2017
Table Global Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
Table Global Opioid-Induced Constipation Sales Share by Application (2016-2025)
Figure Global Sales Opioid-Induced Constipation Market Share by Application (2016-2025)
Figure Global Sales Opioid-Induced Constipation Market Share by Application in 2017
Figure North America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
Figure North America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table North America Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2017
Table North America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2017
Figure United States Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure United States Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Canada Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Mexico Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table North America Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
Table North America Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Market Share by Type
Table North America Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
Table North America Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 North America Opioid-Induced Constipation Market Share by Application
Table North America Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
Table North America Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure North America Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Europe Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
Figure Europe Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Sales Market Share by Countries
Table Europe Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Revenue Market Share by Countries
Figure Germany Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Germany Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure France Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure France Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure UK Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure UK Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Italy Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Russia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
Table Europe Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Market Share by Type
Table Europe Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
Table Europe Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Europe Opioid-Induced Constipation Market Share by Application
Table Europe Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
Table Europe Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Europe Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Asia Pacific Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Unit)
Figure Asia Pacific Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Opioid-Induced Constipation Sales by Countries (2016-2025) (K Unit)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries
Table Asia Pacific Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries
Figure China Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure China Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Japan Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Korea Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure India Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure India Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Figure Southeast Asia Opioid-Induced Constipation Sales Growth Rate (2016-2025) (K Unit)
Figure Southeast Asia Opioid-Induced Constipation Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Opioid-Induced Constipation Sales by Type (2016-2025) (K Unit)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Type
Table Asia Pacific Opioid-Induced Constipation Sales by Application (2016-2025) (K Unit)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Opioid-Induced Constipation Market Share by Application
Table Asia Pacific Opioid-Induced Constipation Sales by Company (2016-2018) (K Unit)
Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Company (2016-2018)
Figure Asia Pacific Opioid-Induced Constipation Sales Market Share by Company in 2017
Figure Central & South America Opioid-Induced Constipation Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Opioid-Induced Constipation Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Opioid-Induced Constipation Sales by Countries (2016-2025) (K Units)
Table Central & South America Opioid-Induced Constipation Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Opioid-Induced Constipation Sales Market Share by Countries
Table Central & South America Opioid-Induced Constipation Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Opioid-Induced Constipation Revenue

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

Other tasks